Find Satranidazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 56302-13-7, Satranidazole [inn], 1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone, 4n7g8a6439, Satranidazol
Molecular Formula
C8H11N5O5S
Molecular Weight
289.27  g/mol
InChI Key
FNSHYEAUAUHIMB-UHFFFAOYSA-N
FDA UNII
4N7G8A6439

Satranidazole
1 2D Structure

Satranidazole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one
2.1.2 InChI
InChI=1S/C8H11N5O5S/c1-10-6(13(15)16)5-9-7(10)11-3-4-12(8(11)14)19(2,17)18/h5H,3-4H2,1-2H3
2.1.3 InChI Key
FNSHYEAUAUHIMB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1C(=CN=C1N2CCN(C2=O)S(=O)(=O)C)[N+](=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
4N7G8A6439
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-methanesulfonyl-3-(1-methyl-5-nitroimidazol-2-yl)-2-imidazolidinone

2. Cg-10213-go

3. Go 10213

4. Go-10213

2.3.2 Depositor-Supplied Synonyms

1. 56302-13-7

2. Satranidazole [inn]

3. 1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one

4. 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone

5. 4n7g8a6439

6. Satranidazol

7. Satranidazol [spanish]

8. Satranidazolum

9. Satranidazolum [latin]

10. 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one

11. Go 10213

12. C 10213 Go

13. Go-10213

14. Brn 0848345

15. Unii-4n7g8a6439

16. 1-methylsulfonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone

17. 2-imidazolidinone, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)-

18. 5-25-09-00447 (beilstein Handbook Reference)

19. Satranidazole [mart.]

20. Satranidazole [who-dd]

21. Schembl1682863

22. Chembl2105542

23. Dtxsid60204840

24. C-10213-go

25. Zinc4217442

26. 1-(1-methyl-5-nitroimidazol-2-yl)-3-(methylsulfonyl)-2-imidazolidinone

27. A924024

28. Q27260233

29. 3-(1-methyl-5-nitroimidazol-2-yl)-1-methylsulfonyl-imidazolidin-2-one

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 289.27 g/mol
Molecular Formula C8H11N5O5S
XLogP3-0.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count2
Exact Mass289.04808964 g/mol
Monoisotopic Mass289.04808964 g/mol
Topological Polar Surface Area130 Ų
Heavy Atom Count19
Formal Charge0
Complexity497
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty